Alan Edward Guttmacher, M.D. (born 1949 in Baltimore, Maryland) was the director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), one of the 27 institutes and centers that comprise the National Institutes of Health (NIH). He oversees the institute’s activities as the focal point at the NIH for research in pediatric health and development, maternal health, reproductive health, intellectual and developmental disabilities, and rehabilitation medicine, among other areas.
A pediatrician and medical geneticist, Dr. Guttmacher came to NIH in 1999 to work at the National Human Genome Research Institute, where he served in a number of roles, including deputy director and acting director, thus overseeing that institute’s efforts to advance genome research, integrate that research into health care, and explore the ethical, legal, and social implications of human genomics. Among Dr. Guttmacher’s areas of expertise is the development of new approaches for translating genomics into better ways of diagnosing, treating, and preventing disease. A major research interest has been the disease, hereditary hemorrhagic telangiectasia.
Dr. Guttmacher received his A.B. degree in 1972 from Harvard College and his M.D. from Harvard Medical School in 1981. From 1982 to 1985, he interned and was a medical resident in pediatrics at Children's Hospital in Boston, Massachusetts. In 1985, he earned a two-year National Research Service Award from the U.S. Public Health Service as a fellow in medical genetics at Children's Hospital Boston and Harvard Medical School.
In 1987, Dr. Guttmacher became director of the Vermont Regional Genetics Center at the University of Vermont College of Medicine where he launched a series of programs in public health genetics, as well as directing the Vermont Cancer Center's Familial Cancer Program, the Vermont Newborn Screening Program, Vermont's only pediatric intensive care unit and the United States' first statewide effort to involve the general public in discussion of the Human Genome Project's ethical, legal, and social implications, supported by the NIH. He also maintained a busy practice in clinical genetics, conducted research, and was a tenured associate professor of pediatrics and medicine at the University of Vermont.